Acorda Therapeutics | ACOR - Attività Correnti



Attività Correnti Cambiamento Data
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
ALKERMES USD 1.93B 187.5M 2025-12
Alterity Therapeutics Limited AUD 27.05M 6.16M 2023-06
Amgen USD 29.06B 1.17B 2025-12
Anika Therapeutics USD 101.59M 2.27M 2025-09
Arrowhead Research USD 1.17B 223.75M 2025-12
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Cara Therapeutics USD 43.13M 4.18M 2025-06
Cipla INR 249.18B 16.3B 2025-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 88.92M 8.72M 2025-09
CSL USD 11.85B 1000K 2025-12
Cytokinetics USD 916.97M 60.37M 2025-12
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Grifols EUR 6.28B 92.48M 2025-09
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Heron Therapeutics USD 229.4M 18.48M 2025-09
Insmed USD 1.79B 137.6M 2025-12
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
MannKind USD 291.58M 67.26M 2025-12
Merck EUR 12.88B 680M 2025-09
Moderna USD 6.54B 54M 2025-12
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Novartis USD 28.2B 2.26B 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Sanofi EUR 30.95B 3.09B 2025-12
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12